Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.490
+0.060 (2.47%)
Jan 2, 2026, 3:38 PM EST - Market open

BDTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
142121145651931,154
Upgrade
Market Cap Growth
-2.06%-16.54%121.66%-66.10%-83.26%-
Upgrade
Enterprise Value
233127-50-13829
Upgrade
Last Close Price
2.432.142.811.805.3332.05
Upgrade
PB Ratio
1.101.451.240.570.993.75
Upgrade
P/TBV Ratio
1.101.451.240.570.993.75
Upgrade
Debt / Equity Ratio
0.160.270.220.240.140.03
Upgrade
Quick Ratio
8.724.796.698.058.8722.16
Upgrade
Current Ratio
8.944.926.828.379.1222.48
Upgrade
Return on Equity (ROE)
19.23%-69.67%-70.94%-58.52%-49.87%-29.17%
Upgrade
Return on Assets (ROA)
6.26%-33.71%-34.33%-28.73%-27.47%-17.82%
Upgrade
Return on Capital (ROIC)
6.95%-38.30%-37.81%-31.51%-29.32%-18.51%
Upgrade
Return on Capital Employed (ROCE)
10.40%-74.30%-62.20%-65.80%-56.60%-22.10%
Upgrade
Earnings Yield
15.53%-57.54%-56.82%-139.28%-65.04%-5.83%
Upgrade
FCF Yield
15.42%-51.45%-46.00%-130.27%-53.27%-4.53%
Upgrade
Buyback Yield / Dilution
-6.44%-25.19%-21.00%-0.38%-9.97%-1485.31%
Upgrade
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q